WT1 and acute myeloid leukemia: The up-regulation of miR-155 was associated with an unfavourable clinical outcome independently in CN-AML, miR-130a associated with high expression of WT1, and the down-regulation of miR-148a and miR-193a contributed AML leukemogenesis.